Mar 19, 2025
3 Reasons CLOV is Risky and 1 Stock to Buy Instead
Even during a down period for the markets, Clover Health has gone against the grain, climbing to $3.82. Its shares have yielded a 26.1% return over the last six months, beating the S&P 500 by 27.7%. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.